CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice

J Immunol. 2010 Dec 15;185(12):7654-62. doi: 10.4049/jimmunol.1000927. Epub 2010 Nov 8.

Abstract

Chronic hepatitis B virus (HBV) infection is characterized by sustained liver inflammation with an influx of lymphocytes, which contributes to the development of cirrhosis and hepatocellular carcinoma. The mechanisms underlying this immune-mediated hepatic pathogenesis remain ill defined. We report in this article that repetitive infusion of anti-CD137 agonist mAb in HBV-transgenic mice closely mimics this process by sequentially inducing hepatitis, fibrosis, cirrhosis, and, ultimately, liver cancer. CD137 mAb initially triggers hepatic inflammatory infiltration due to activation of nonspecific CD8(+) T cells with memory phenotype. CD8(+) T cell-derived IFN-γ plays a central role in the progression of chronic liver diseases by actively recruiting hepatic macrophages to produce fibrosis-promoting cytokines and chemokines, including TNF-α, IL-6, and MCP-1. Importantly, the natural ligand of CD137 was upregulated significantly in circulating CD14(+) monocytes in patients with chronic hepatitis B infection and closely correlated with development of liver cirrhosis. Thus, sustained CD137 stimulation may be a contributing factor for liver immunopathology in chronic HBV infection. Our studies reveal a common molecular pathway that is used to defend against viral infection but also causes chronic hepatic diseases.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / pathology
  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / immunology*
  • Carcinoma, Hepatocellular / metabolism
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / virology
  • Cytokines / genetics
  • Cytokines / immunology
  • Cytokines / metabolism
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology*
  • Hepatitis B, Chronic / genetics
  • Hepatitis B, Chronic / immunology
  • Hepatitis B, Chronic / metabolism
  • Humans
  • Immunologic Memory / drug effects
  • Immunologic Memory / genetics
  • Immunologic Memory / immunology
  • Lipopolysaccharide Receptors / genetics
  • Lipopolysaccharide Receptors / immunology
  • Lipopolysaccharide Receptors / metabolism
  • Liver Neoplasms, Experimental / genetics
  • Liver Neoplasms, Experimental / immunology*
  • Liver Neoplasms, Experimental / metabolism
  • Liver Neoplasms, Experimental / pathology
  • Liver Neoplasms, Experimental / virology
  • Mice
  • Mice, Transgenic
  • Monocytes / immunology*
  • Monocytes / metabolism
  • Monocytes / pathology
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / agonists
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / biosynthesis
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / immunology*
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / genetics
  • Up-Regulation / immunology

Substances

  • Antibodies, Monoclonal
  • Cytokines
  • Lipopolysaccharide Receptors
  • Tumor Necrosis Factor Receptor Superfamily, Member 9